Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mubeccel Akdis

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Allergy|February 18, 2020
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthmaIoana Agache, Claudio Rocha, Jessica Beltran, et al.
Allergy|February 9, 2020
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthmaIoana Agache, Jessica Beltran, Cezmi Akdis, et al.
Allergy|March 11, 2020
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthmaIoana Agache, Yang Song, Claudio Rocha, et al.
Allergy|May 23, 2024
The impact of exposure to tobacco smoke and e-cigarettes on asthma-related outcomes: Systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthmaIoana Agache, Ignacio Ricci-Cabello, Carlos Canelo-Aybar, et al.
The World Allergy Organization Journal|October 26, 2016
Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization StatementMarek L Kowalski, Ignacio Ansotegui, Werner Aberer, et al.
The World Allergy Organization Journal|January 20, 2017
Erratum to: Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization StatementMarek L Kowalski, Ignacio Ansotegui, Werner Aberer, et al.
Allergy|September 21, 2022
Implementation of the web-based calculator estimating odds ratio of severe COVID-19 for unvaccinated individuals in a country with high coronavirus-related death tollMiroslaw Kwasniewski, Urszula Korotko, Karolina Chwialkowska, et al.
Allergy|October 30, 2024
EAACI guidelines on the management of IgE-mediated food allergyAlexandra F Santos, Carmen Riggioni, Ioana Agache, et al.
Allergy|October 10, 2023
EAACI guidelines on the diagnosis of IgE-mediated food allergyAlexandra F Santos, Carmen Riggioni, Ioana Agache, et al.
The Journal of Allergy and Clinical Immunology|February 11, 2017
Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypesJosep M Anto, Jean Bousquet, Mubeccel Akdis, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Allergy|February 18, 2020
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthmaIoana Agache, Claudio Rocha, Jessica Beltran, et al.
Allergy|February 9, 2020
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthmaIoana Agache, Jessica Beltran, Cezmi Akdis, et al.
Allergy|March 11, 2020
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthmaIoana Agache, Yang Song, Claudio Rocha, et al.
Allergy|May 23, 2024
The impact of exposure to tobacco smoke and e-cigarettes on asthma-related outcomes: Systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthmaIoana Agache, Ignacio Ricci-Cabello, Carlos Canelo-Aybar, et al.
The World Allergy Organization Journal|October 26, 2016
Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization StatementMarek L Kowalski, Ignacio Ansotegui, Werner Aberer, et al.
The World Allergy Organization Journal|January 20, 2017
Erratum to: Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization StatementMarek L Kowalski, Ignacio Ansotegui, Werner Aberer, et al.
Allergy|September 21, 2022
Implementation of the web-based calculator estimating odds ratio of severe COVID-19 for unvaccinated individuals in a country with high coronavirus-related death tollMiroslaw Kwasniewski, Urszula Korotko, Karolina Chwialkowska, et al.
Allergy|October 30, 2024
EAACI guidelines on the management of IgE-mediated food allergyAlexandra F Santos, Carmen Riggioni, Ioana Agache, et al.
Allergy|October 10, 2023
EAACI guidelines on the diagnosis of IgE-mediated food allergyAlexandra F Santos, Carmen Riggioni, Ioana Agache, et al.
The Journal of Allergy and Clinical Immunology|February 11, 2017
Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypesJosep M Anto, Jean Bousquet, Mubeccel Akdis, et al.
Pageof 7